Skip to main content

Blog

Tell Us About the Products You Buy to Make Your Home Healthier

The Asthma and Allergy Foundation of America (AAFA) is conducting a survey to learn more about the products you buy for your family and how they impact your homes’ health. We want to hear your thoughts about product claims and your experience with CERTIFIED asthma & allergy friendly® products and services. Take our quick survey to let us know how you shop for home products. The survey should take 15 minutes or less to complete. TAKE THE SURVEY NOW Take the survey by Nov. 5, 2020, at...

Facebook Live Chat: The Latest From the NIH on COVID-19, Asthma and Food Allergies

Join AAFA President and CEO Kenneth Mendez as he talks with experts from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) about the latest research on COVID-19, asthma and food allergies. When: Tuesday, Nov. 10, 2020, 1:30 – 2 p.m. ET (10:30 – 11 a.m. PT) Where: AAFA's Facebook page – watch the session live or later from your computer, iOS or Android device. RSVP: Click the "Going" icon on our Facebook event to receive a reminder...

AAFA Receives CDC Funding Award to Improve Asthma Care and Outcomes for At-Risk Populations Through Comprehensive Community Health Interventions

The Asthma and Allergy Foundation of America (AAFA) is spearheading yet another new venture geared toward improving health outcomes for our nation’s most at-risk groups affected by asthma. These groups include Black, Hispanic and Indigenous Americans, senior adults, expectant mothers, children with asthma, and our nation’s military who have developed asthma while in service.

Will You Help Prevent a Flu/COVID-19 “Twindemic”?

As we continue to fight COVID-19 , we are now in flu season too. Get your flu shot and join the staff at the Asthma and Allergy Foundation of America (AAFA) to prevent a “twindemic.” What Is a “Twindemic” and Why Should You Be Concerned? A “twindemic” is a word used to describe the spread of the flu and the new coronavirus that causes COVID-19 at the same time. As we have seen, COVID-19 spreads easily. So far, it has been responsible for millions of infections and hundreds of thousands of...

Ask the Experts: Managing Asthma During the COVID-19 Pandemic (Video and Resources)

An expert panel from the Asthma and Allergy Foundation of America (AAFA) and the Improving Pediatric Asthma Care in the District of Columbia (IMPACT DC) Asthma Clinic at Children’s National Hospital answered your questions about managing asthma during the COVID-19 pandemic. Our expert panel discussed: Access to asthma health care during the COVID-19 pandemic Asthma management strategies, including preventing respiratory illnesses Making decisions for in-person and stay-at-home learning and...

How Can You Tell the Difference Between COVID-19, a Cold, the Flu, Allergies and Asthma?

Cold and flu season is here, and the new coronavirus that causes COVID-19 is still spreading. With every cough or sniffle, you may wonder if it’s asthma or allergies, the flu, the common cold or even COVID-19. But how can you tell the difference? The Asthma and Allergy Foundation of America (AAFA) has created a respiratory symptoms chart to help you recognize the difference between these conditions. Click to see larger image (English) Click to see larger image (Spanish) Asthma Symptoms...

Survey: Impacts of COVID-19 and the Flu on People With Asthma and Allergies

In March 2020, the World Health Organization classified COVID-19 as a global pandemic. This fall and winter, the Centers for Disease Control and Prevention (CDC) believes flu viruses and the new coronavirus that causes COVID-19 will spread at the same time. The Asthma and Allergy Foundation of America (AAFA) wants to hear about the experiences, perceptions and needs of people with asthma and allergies as they relate to COVID-19 and the flu. We hope to better serve the asthma and allergy...

New Webinar: Managing Asthma During the COVID-19 Pandemic

Experts from the Asthma and Allergy Foundation of America (AAFA) and the Improving Pediatric Asthma Care in the District of Columbia (IMPACT DC) Asthma Clinic at Children’s National Hospital will talk about managing your asthma during the COVID-19 pandemic. RSVP now for our free webinar on Tuesday, Oct. 20, 2020, at 2 p.m. ET (11 a.m. PT). REGISTER NOW Our expert panel will discuss: Access to asthma health care during the COVID-19 pandemic, especially in hardest-hit communities Asthma...

House Passes Bill Protecting Students With Asthma and Allergies, Moves to Senate for Vote

Update: It's official! On Jan. 5, 2021, the president signed the School-Based Allergies and Asthma Management Program Act into law. Thank you to our community. Your efforts helped to get this bill signed into law, which will help thousands of students with asthma and allergies and their families nationwide. On Sept. 29, 2020, the House of Representatives passed the School-Based Allergies and Asthma Management Program Act (H.R. 2468) . If passed by the Senate and signed into law by the...

Causes of Fall Allergy Symptoms and What You Can Do About Them

Ah, fall! Time for cozy jackets, colorful leaves, pumpkin spice lattes and … allergy medicine? If you’ve noticed the change in season also triggers allergy and asthma symptoms, you’re not alone. Just like spring, fall is a time when many people are seeking relief from their seasonal allergies . Common symptoms of seasonal allergies include: Runny nose and mucus Sneezing Itchy nose, eyes, ears and mouth Stuffy nose (nasal congestion) Red and watery eyes Swelling around the eyes Do You Live in...

Teva Announces Two More Digital Inhalers for Asthma - AirDuo® Digihaler® and ArmonAir® Digihaler®

Teva Respiratory, LLC., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced the launch of AirDuo® Digihaler® (fluticasone propionate and salmeterol) inhalation powder and ArmonAir® Digihaler® (fluticasone propionate) inhalation powder, two digital maintenance inhalers for patients with asthma. AirDuo® Digihaler® is a prescription medicine used to control symptoms of asthma and to prevent symptoms such as wheezing in people 12 years of age and older.

Trelegy Ellipta Inhaler Is Now Approved for Asthma Treatment

GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) announced the US Food and Drug Administration (FDA) has approved a new indication for Trelegy Ellipta (fluticasone furoate / umeclidinium / vilanterol ‘FF/UMEC/VI’) for the treatment of asthma in patients aged 18 years and older adding to its current license for use in patients with chronic obstructive pulmonary disease (COPD). Trelegy Ellipta is not indicated for relief of acute bronchospasm.

Perrigo Generic Albuterol Inhaler Recalled Due to Clogging

Perrigo Company plc today announced a voluntary U.S. nationwide recall of albuterol sulfate inhalation aerosol to the retail level after previously halting production and distribution. These actions are being taken out of an abundance of caution as a result of complaints that some units may not dispense due to clogging. Perrigo's generic albuterol sulfate inhalation aerosol was developed in partnership with and manufactured by Catalent Pharma Solutions.

Post
×
×
×
×